To Test an e-Health Educational Intervention Patients With an ICD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Ulster

About this trial

Role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study will build on previous research by designing, in collaboration with patients, family members and professionals, an online resource to provide important information that can lower anxiety and concerns, and improve quality of life. The CHOICE-ICD resource will be easy to use, incorporating games and quizzes to encourage engagement, up to date information appropriate to each patient's needs, as well as animation clips, virtual reality, and short patient videos. CHOICE-ICD will be made available to 64 patients, in addition to normal care, awaiting or with a recently implanted ICD in Belfast and Glasgow. Patients will use the resource for 3 months. Patients and family members will then be asked to complete questionnaires and participate in semi-structured interviews. This study will develop 1st UK online resource providing information to enable patients to have greater choice and control in their care.

Eligibility criteria

Qualifiers

Patients with heart failure awaiting or with an ICD (no time restriction on implantation)

No cognitive impairment

Have contact with the patient at least 5 times per week.

Be physically and mentally capable of participation (self-assessment)

Disqualifiers

Patients, judged by their Cardiologist as physically or mentally unsuitable to complete the study.

Patients or caregivers lacking capacity to give consent.

Patients who have known pregnancy

Caregivers who's patient is unwilling to take participate

Trial design

Treatments tested in this trial

  • Choice-ICD

Treatment groups

256 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Ulster

Lead sponsor

Belfast Health and Social Care Trust

Collaborator

Golden Jubilee National Hospital

Collaborator